However, compared to Lv-shRNA-NDUFA4L2, the Lv-shRNA-NDUFA4L2 + Mdivi-1 treatment group showed more efficient suppression of subcutaneous tumor growth. This evidence concerns the gene COXFA4L2 and neoplasm.